Publication | Closed Access

The transgenic chicken derived anti-CD20 monoclonal antibodies exhibits greater anti-cancer therapeutic potential with enhanced Fc effector functions

Cancer ImmunosurveillanceTransgenic ChickenImmunologyTumor ImmunityAntibody EngineeringImmunotherapeuticsImmunotherapyMedicineRadiation OncologyAnti-cd20 Monoclonal Antibodies